Mirae Asset Securities »

Crispr Therapeutics shares owned by Mirae Asset Securities

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Mirae Asset Securities from 13F filings

Historical chart of Mirae Asset Securities investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Mirae Asset Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Mirae Asset Securities

Quarter filed Position value Share count Share price at filing
2024-06-30 $812k 15k 54.01

More positions owned by Mirae Asset Securities

Select Sector Spdr Tr Indl Indl (XLI)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Ser Tr S&p Retail Etf (XRT)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Ishares Tr Ishares Semicdtr (SOXX)
Select Sector Spdr Tr Sbi Materials (XLV)
Spdr Ser Tr S&p Oilgas Exp (XOP)
Spdr Ser Tr S&p Biotech (XBI)
Select Sector Spdr Tr Sbi Int-utils Sbi Int-utils (XLU)
Spdr Ser Tr S&p Homebuild (XHB)
Apple (AAPL)
Spdr Ser Tr S&p Regl Bkg (KRE)

View all positions for Mirae Asset Securities

Top funds holding Crispr Therapeutics

Capital Research and Management Company - Division 3
ARK Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
BlackRock
T. Rowe Price Investment Management
State Street Corporation
FMR
Vanguard Group
NEA Management Company
EcoR1 Capital
Citadel Advisors
Susquehanna International
Bank of America Corporation
Sr One Capital Management

View all funds holding Crispr Therapeutics